Identifying Antibiotic Resistance Through Direct Detection of Intact Enzymes from Bacterial Lysates using LC-MS/MS: Exploring MRSA and Carbapenem Resistance

Importance of the Topic

Antibiotic resistance poses a growing global health threat, driven by the spread of MRSA and carbapenemase-producing Gram-negative bacteria. Rapid identification of resistance enzymes at the protein level can guide targeted therapies, improve patient outcomes, and inform infection control measures. Direct detection of intact resistance proteins via LC-MS/MS offers a promising approach for timely and accurate resistance profiling.

Objectives and Study Overview

This work aims to develop and validate an LC-MS/MS workflow for the direct detection and characterization of intact resistance enzymes from bacterial lysates. The study focuses on two major resistance mechanisms: PBP2a in MRSA and five families of carbapenemases (KPC, NDM, VIM, IMP, OXA-48). Key objectives include demonstrating variant-specific detection, establishing identification criteria, and evaluating the method across multiple bacterial species.

Methodology and Used Instrumentation

Sample Preparation:

• Bacterial isolates (CDC/FDA Antibiotic Resistance Isolate Bank, ATCC) cultured on agar or in broth.
• Cell lysis by bead-beating or sonication; protein extraction in urea or guanidinium chloride buffers.
• Bottom-up digestion: trypsin treatment and C18 spin column cleanup.

Chromatography and Mass Spectrometry:

• Intact proteins separated on ProSwift RP4H reverse-phase column or online SPE; binary gradients of water/acetonitrile in 0.2% formic acid.
• Instrumentation platforms: Thermo Scientific Ultimate 3000, Vanquish Horizon, EASY-nLC, in-house prototype.
• Mass analysis on Q-Exactive HF with high-resolution, accurate-mass detection; MS/MS fragmentation for sequence confirmation.

Data Analysis:

• Bottom-up: Proteome Discoverer 2.5 with Sequest HT, supplemented by Protein Prospector for manual spectrum validation.
• Custom databases from UniProt and ResFinder for resistance marker identification.
• Identification criteria: precursor isolation window, fragment m/z within ±10 ppm, signal-to-noise ≥3, correct charge state; minimum three diagnostic fragments per protein.

Main Results and Discussion

The workflow enabled confident detection of mature PBP2a and multiple carbapenemase variants across diverse species. High-resolution intact mass measurements often distinguished closely related isoforms. MS/MS fragmentation provided sequence-informative ions even when precursor signals were weak. Key observations included:

• Signal peptide cleavage varied from predicted sites, affecting mature mass; dominant N-terminal sequences were experimentally determined.
• Post-translational modifications and discrepant cleavage events led to mass deviations requiring careful confirmation.
• Multiple resistance markers were detected and differentiated in single analyses, demonstrating multiplex capability.

Chromatographic optimization reduced analysis time while preserving separation quality. Peripheral localization of targeted proteins in cells influenced extraction efficiency but did not compromise detection.

Benefits and Practical Applications

This LC-MS/MS approach offers:

• Rapid and specific identification of resistance enzymes at the variant level, supporting precision antimicrobial therapy.
• Simultaneous detection of multiple markers from a single sample, enhancing laboratory throughput.
• High sensitivity compared to MS alone, overcoming challenges of complex lysate backgrounds.
• A straightforward experimental setup compatible with standard proteomics platforms.

Applications include clinical diagnostics, surveillance of resistance dissemination, and in-depth research on enzyme variants.

Future Trends and Opportunities

Advancements may include automated data interpretation pipelines, integration with clinical microbiology workflows, and expansion to additional resistance mechanisms beyond beta-lactamases. Emerging high-throughput platforms and miniaturized sample preparation could further reduce turnaround times. Adaptation to point-of-care or near-patient instruments may transform antimicrobial stewardship practices.

Conclusion

The described LC-MS/MS strategy enables direct, intact-protein detection of antibiotic resistance enzymes with high confidence and specificity. By combining optimized chromatography, high-resolution mass analysis, and stringent identification criteria, the method accurately distinguishes enzyme variants across bacterial species. This approach holds significant promise for clinical diagnostics and resistance monitoring.

References

1. Michael CA et al. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014.
2. Ventola CL. The Antibiotic Resistance Crisis. P&T. 2015.
3. CDC. Antibiotic Resistance Threats in the United States, 2019. U.S. Department of Health and Human Services.
4. Bonomo RA et al. Carbapenemase-Producing Organisms: A Global Scourge. Clin Infect Dis. 2018.
5. Neil JR et al. Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a protein. Sci Rep. 2021.
6. McGee WM et al. Direct detection of intact Klebsiella pneumoniae carbapenemase variants from cell lysates. Clin Mass Spectrom. 2020.
7. McGee WM et al. Direct detection of OXA-48-like carbapenemase variants with and without co-expression of ESBLs using mass spectrometry. J Mass Spectrom Adv Clin Lab. 2021.